Stock 2269 WUXI BIOLOGICS (CAYMAN) INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News WuXi Biologics (Cayman) Inc.

Equities

2269

KYG970081173

Delayed Hong Kong S.E.
Other stock markets
 07:32:16 26/06/2024 am IST 		5-day change 1st Jan Change
11.9 HKD +0.17% Intraday chart for WuXi Biologics (Cayman) Inc. +1.71% -59.86%
19/06 Wuxi Biologics Terms US Plant's Expansion Halt as Normal Business Adjustment MT
13/06 WuXi Biologics Surges to 19-Month High Wednesday on Hopes of Avoiding US Ban MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wuxi Biologics Terms US Plant's Expansion Halt as Normal Business Adjustment
MT
WuXi Biologics Named to MSCI ESG Leaders Indexes for Second Consecutive Year
AQ
WuXi Biologics Cayman : Named to MSCI ESG Leaders Indexes for Second Consecutive Year
PU
WuXi Biologics Surges to 19-Month High Wednesday on Hopes of Avoiding US Ban
MT
WuXi Biologics Enhances Manufacturing Capability with the Installation of Three 5,000L Single-Use Bioreactors
AQ
WuXi facility boosts bioprocessing capacity with new bioreactors
AQ
US lawmakers ask FBI for briefing on GenScript Biotech's links to China
RE
US lawmakers ask FBI for briefing on GenScript Biotech's links to China
RE
China stocks rise as industrial profits grow; energy, semiconductor shares lead gains
RE
Wuxi Biologics (Cayman) Maintains it is Not a Security Threat After House Bill Changes; Stocks Drop 3%
MT
US House committee advances bill to restrict BGI, WuXi AppTec
RE
US House committee to vote on bill to restrict BGI, WuXi AppTec
RE
US Congress Drafts Bill Asking Drug Firms to Unlink from Chinese Biotech Firms
MT
WuXi Shares Volatile as U.S. Bill Revised to Set Deadline for Decoupling
DJ
U.S. bill to restrict WuXi AppTec, other Chinese biotech cos revised to give more time to cut ties
RE
Pacific Assets Trust cautiously optimistic after outpacing benchmark
AN
WuXi Biologics Cayman : Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment
PU
WuXi Biologics Selected for S&P Global Sustainability Yearbook 2024
AQ
WuXi Biologics Wins 2024 CDMO Leadership Awards in All Categories
AQ
Wuxi Biologics Inc. Announces Retirement of Weichang Zhou as Chief Technology Officer and President of Global Biologics Development and Operations and Re-Designates as Non-Executive Director and Honorary President of Global Biologics Development and Operations and Senior Advisor to Chief Executive Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2269 Stock
  4. News WuXi Biologics (Cayman) Inc.